JP2022546711A5 - - Google Patents
Info
- Publication number
- JP2022546711A5 JP2022546711A5 JP2022514215A JP2022514215A JP2022546711A5 JP 2022546711 A5 JP2022546711 A5 JP 2022546711A5 JP 2022514215 A JP2022514215 A JP 2022514215A JP 2022514215 A JP2022514215 A JP 2022514215A JP 2022546711 A5 JP2022546711 A5 JP 2022546711A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- formula
- independently
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962895476P | 2019-09-03 | 2019-09-03 | |
| US62/895,476 | 2019-09-03 | ||
| PCT/US2020/049248 WO2021046250A1 (en) | 2019-09-03 | 2020-09-03 | Methods of treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546711A JP2022546711A (ja) | 2022-11-07 |
| JP2022546711A5 true JP2022546711A5 (https=) | 2023-08-21 |
| JP7631319B2 JP7631319B2 (ja) | 2025-02-18 |
Family
ID=74853030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514215A Active JP7631319B2 (ja) | 2019-09-03 | 2020-09-03 | 治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12599603B2 (https=) |
| EP (1) | EP4025218A4 (https=) |
| JP (1) | JP7631319B2 (https=) |
| KR (1) | KR20220054853A (https=) |
| CN (1) | CN114340636A (https=) |
| AU (1) | AU2020343329C1 (https=) |
| BR (1) | BR112022003670A2 (https=) |
| CA (1) | CA3147071A1 (https=) |
| IL (1) | IL290983A (https=) |
| MX (1) | MX2022002607A (https=) |
| WO (1) | WO2021046250A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020146384A1 (en) | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20220054853A (ko) | 2019-09-03 | 2022-05-03 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치료 방법 |
| MX2024010993A (es) * | 2022-03-11 | 2024-09-17 | Intra Cellular Therapies Inc | Compuestos organicos. |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4690935A (en) | 1983-03-31 | 1987-09-01 | Wayne State University | Inhibition of tumor growth and metastasis with calcium channel blocker compounds |
| AU2006255028B2 (en) | 2005-06-06 | 2012-04-19 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20120012831A (ko) | 2007-12-06 | 2012-02-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| KR20110103949A (ko) | 2008-12-06 | 2011-09-21 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| MA32942B1 (fr) * | 2008-12-06 | 2012-01-02 | Intra Cellular Therapies Inc | Composes organiques |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| WO2012177263A1 (en) | 2011-06-24 | 2012-12-27 | Intra-Cellular Therapies, Inc. | Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists |
| JP6224597B2 (ja) | 2011-09-27 | 2017-11-01 | バイオメッド バレー ディスカバリーズ，インコーポレイティド | グリオーマを処置するための組成物及び方法 |
| WO2013138118A1 (en) | 2012-03-14 | 2013-09-19 | The Regents Of The University Of California | Treatment of inflammatory disorders in non-human mammals |
| CA2877146C (en) | 2012-06-18 | 2020-10-20 | Dart Neuroscience (Cayman) Ltd | Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds |
| EP2968338B1 (en) | 2013-03-15 | 2019-01-09 | Intra-Cellular Therapies, Inc. | Pde1 inhibitors for use in the treatment and/or prevention of cns injuries, and pns diseases, disorders or injuries |
| KR102240326B1 (ko) | 2013-03-15 | 2021-04-13 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| JP6696904B2 (ja) | 2014-01-08 | 2020-05-20 | イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． | 製剤および医薬組成物 |
| EP3157926B1 (en) | 2014-06-20 | 2019-05-15 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US10131671B2 (en) * | 2014-08-07 | 2018-11-20 | Intra-Cellular Therapies, Inc. | Organic compounds |
| CA2961212C (en) | 2014-09-17 | 2024-02-06 | Intra-Cellular Therapies, Inc. | Compounds and methods |
| US10849862B2 (en) * | 2014-12-26 | 2020-12-01 | Theravalues Corporation | Formulation of curcumin and anti-PD-1 antibody |
| JP2018515474A (ja) | 2015-04-28 | 2018-06-14 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 抗ｐｄ−１抗体を使用するｐｄ−ｌ１陽性黒色腫の処置 |
| CA2991628C (en) | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| KR20180105685A (ko) * | 2016-02-08 | 2018-09-28 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 투카레솔 또는 이의 유사체를 함유하는 조성물 |
| JP7134168B6 (ja) | 2016-09-12 | 2024-02-02 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 新規使用 |
| WO2018093591A1 (en) | 2016-11-03 | 2018-05-24 | Juno Therapeutics, Inc. | Combination therapy of a cell based therapy and a microglia inhibitor |
| EP3558319A4 (en) | 2016-12-22 | 2020-07-22 | AbbVie Inc. | COMPOSITIONS AND PROCESSES FOR IMPROVING OR INCREASING THE PRODUCTION OF TYPE I IFN |
| EP3612839A1 (en) | 2017-04-20 | 2020-02-26 | ADC Therapeutics SA | Combination therapy |
| TW201920104A (zh) | 2017-08-31 | 2019-06-01 | 美商馬愈法瑪公司 | 外核苷酸焦磷酸酶-磷酸二酯酶1(enpp-1)抑制劑及其用途 |
| US20210338679A1 (en) | 2018-09-25 | 2021-11-04 | Intra-Cellular Therapies, Inc. | Novel uses |
| WO2020146384A1 (en) * | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20220054853A (ko) | 2019-09-03 | 2022-05-03 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치료 방법 |
| MX2024010993A (es) | 2022-03-11 | 2024-09-17 | Intra Cellular Therapies Inc | Compuestos organicos. |
-
2020
- 2020-09-03 KR KR1020227010604A patent/KR20220054853A/ko active Pending
- 2020-09-03 US US17/640,050 patent/US12599603B2/en active Active
- 2020-09-03 AU AU2020343329A patent/AU2020343329C1/en active Active
- 2020-09-03 CN CN202080062144.3A patent/CN114340636A/zh active Pending
- 2020-09-03 MX MX2022002607A patent/MX2022002607A/es unknown
- 2020-09-03 WO PCT/US2020/049248 patent/WO2021046250A1/en not_active Ceased
- 2020-09-03 CA CA3147071A patent/CA3147071A1/en active Pending
- 2020-09-03 JP JP2022514215A patent/JP7631319B2/ja active Active
- 2020-09-03 EP EP20860677.2A patent/EP4025218A4/en active Pending
- 2020-09-03 BR BR112022003670A patent/BR112022003670A2/pt unknown
-
2022
- 2022-02-28 IL IL290983A patent/IL290983A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022546711A5 (https=) | ||
| RU2468021C2 (ru) | Гетероциклические соединения и их применение | |
| JP2020533277A5 (https=) | ||
| RU2602498C2 (ru) | Соединения и композиции для стабилизации индуцируемого гипоксией фактора-2 альфа как способ лечения рака | |
| JP2025163128A5 (https=) | ||
| JP2022185107A5 (https=) | ||
| JP2020521740A5 (https=) | ||
| JP2020505396A5 (https=) | ||
| JP2017528498A5 (https=) | ||
| RU2008143237A (ru) | Биологически доступная для перорального применения кофейная кислота, относящаяся к противоопухолевым лекарственным средствам | |
| RU2002117422A (ru) | 4-пиримидинил-N-ацил-L-фенилаланины | |
| RU2006112593A (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 и/или syk | |
| RU2002120515A (ru) | Гетероциклические соединения, содержащие сульфонамидные группы | |
| RU2001121987A (ru) | Замещенные 1-оксо- и 1,3-диоксоизоиндолины и их применение в фармацевтических композициях для снижения уровней воспалительных цитокинов | |
| JP2023509359A5 (https=) | ||
| CA2550350A1 (en) | 2-(hetero)aryl-substituted tetrahydroquinoline derivatives | |
| RU2003127731A (ru) | Ингибиторы металлопротеиназ | |
| JP2023510746A5 (https=) | ||
| CA2617991A1 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
| JP2025508323A5 (https=) | ||
| JP2022522942A5 (https=) | ||
| KR920006322A (ko) | 벤젠, 피리딘 및 피리미딘 유도체 | |
| JP2023538159A5 (https=) | ||
| RU2010107603A (ru) | Производные n-(2-тиазолил)амида для лечения ожирения, диабетов и сердечно-сосудистых заболеваний | |
| JP2025509446A5 (https=) |